Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls

INTENSIVE CARE MEDICINE

SPRINGER

1. Innovative Medicines Initiative Joint Undertaking (IMI JU) [115523]
2. Combatting Bacterial Resistance in Europe (COMBACTE) from the European Union
3. European Federation of Pharmaceutical Industries and Associations (EFPIA) companies